Skip to content

Evaluation of CD4 T cell count and its subsets in patients with major depressive disorder

Evaluation of CD4 T cell count and its subsets Th1 ,Th2 and Th17 cells in patients with major depressive disorder - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071516
Enrollment
60
Registered
2024-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F321- Major depressive disorder, singleepisode, moderate

Interventions

Control Intervention1: Nil: Nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than eighteen years Patient having major depressive episode without psychotic symptoms for at least two weeks according to ICD eleven criteria First onset MDD Patients attended and evaluated by senior residents or consultants Indication of anti depressant therapy Patients agreeing to be part of the study Brief Adherence Rating Scale more than eighty percent on follow up after eight weeks of treatment Controls Age and gender matched healthy volunteers who come to OPD of GIPMER LNH GNEC New Delhi General Health Questionnaire twelve items (GHQ less than three

Exclusion criteria

Exclusion criteria: Any other psychiatric diagnosis except MDD Substance use except nicotine containing agents Disorders due to substance use include disorders that result from a single occasion or repeated use of substances that have psychoactive properties including certain medications Acute and chronic major physical illness Independent variables MDD and its severity Anti depressant therapy Demography and socioeconomic status Patient with MDD will be treated as per SOP of Department of Psychiatry GIPMER

Design outcomes

Primary

MeasureTime frame
CD 4 T Cell count Th1 th2 th17 cell count Timepoint: 6 months

Secondary

MeasureTime frame
Treatment response treatment resistant depressionTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Madhumitha Surulirajan

Maulana Azad Medical College

lchandra70@yahoo.com9873167313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026